Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy

Turk J Gastroenterol. 2023 Mar;34(3):308-309. doi: 10.5152/tjg.2023.23070.

Author

Zeynep Gök Sargın¹

Affiliation

¹ Department of Gastroenterology and Hepatology, Kırıkkale University Faculty of Medicine, Kırıkkale, Turkey.

PMID: 36919836
DOI: 10.5152/tjg.2023.23070

No abstract available

MeSH terms

Antiviral Agents / therapeutic use
Biological Therapy
DNA, Viral
Hepatitis B Antibodies
Hepatitis B Core Antigens
Hepatitis B Surface Antigens*
Hepatitis B virus / physiology
Hepatitis B* / drug therapy
Humans

Substances

Hepatitis B Surface Antigens
Hepatitis B Core Antigens
Hepatitis B Antibodies
DNA, Viral
Antiviral Agents